Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Hypertrophy, Right Ventricular

fluorodeoxyglucose f18 has been researched along with Hypertrophy, Right Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Igata, S; Kumagai, E; Kurata, S; Nakamura, T; Sugiyama, Y; Sun, J; Tahara, A; Tahara, N1
Aldighieri, F; Alonso, G; Duarte, PS; Machado, C; Martins, LR; Zhuang, H1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Hypertrophy, Right Ventricular

ArticleYear
Myocardial metabolic improvement prior to electrocardiographic or volumetric changes of the right ventricle in pulmonary arterial hypertension.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:1

    Topics: Adult; Asthma; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Myocardium; Positron Emission Tomography Computed Tomography; Tricuspid Valve Insufficiency

2018
Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:8

    Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Heart Diseases; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Neoplasms; Male; Middle Aged; Pulmonary Emphysema; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed

2002